Trials / Conditions / Astrocytoma, Grade II
Astrocytoma, Grade II
5 registered clinical trials studyying Astrocytoma, Grade II.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Radiotherapy in IDH Mutated Glioma: Evaluation of Late Outcomes NCT04304300 | Erasmus Medical Center | — |
| Terminated | FORWARD Optune and Adjuvant TMZ in Grade II/III Astrocytoma NCT03906448 | University of Florida | Phase 2 |
| Terminated | A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG) NCT02924038 | Nicholas Butowski | Phase 1 |
| Completed | Neo-adjuvant Evaluation of Glioma Lysate Vaccines in WHO Grade II Glioma NCT02549833 | Jennie Taylor | Phase 1 |
| Terminated | Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors NCT01836549 | Pediatric Brain Tumor Consortium | Phase 2 |